InvestorsHub Logo
Followers 65
Posts 2029
Boards Moderated 0
Alias Born 10/31/2017

Re: Chiugray post# 434297

Thursday, 01/13/2022 7:48:19 PM

Thursday, January 13, 2022 7:48:19 PM

Post# of 701566
My view is that FDA uses Advisory Committees if they are torn about what to do (rarely) or if they are trying to bolster support for what they plan to do when they don’t think the decision would be met well by physicians or patients. Again, what I have witnessed is that they place higher value on patient/caregiver public comments over the AC as well.

Here, the public comment piece is a SLAM DUNK,. So if physicians are on board, no need for a committee. From what I can tell, through whar we all share here, but also through industry friends who actually engage some top neurooncologists, their is no need to bulster expert support either. Those tapped into the development products are full swing eager to get their hands on DCVax.

I will be absolutely shocked if an Advisory Committee is called on for DCVax. The usual case is no AC. With Stuup coming around, the only naysayers are those trying to contain this stock.

We are golden!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News